abrdn Life Sciences Investors
HQL
39 hedge funds and large institutions have $46.1M invested in abrdn Life Sciences Investors in 2013 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 1 closing their positions.
700% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 1
78% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 9
22% more funds holding
Funds holding: 32 → 39 (+7)
9% more capital invested
Capital invested by funds: $42.3M → $46.1M (+$3.8M)
0.15% more ownership
Funds ownership: 16.12% → 16.27% (+0.15%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NPC
National Planning Corporation
El Segundo,
California
|
+$580K |
| 2 |
Morgan Stanley
New York
|
+$544K |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$481K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$443K |
| 5 |
SFS
Shaker Financial Services
Arlington,
Virginia
|
+$443K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAM
Advisors Asset Management
Monument,
Colorado
|
-$2.43M |
| 2 |
OFG
OTA Financial Group
Purchase,
New York
|
-$303K |
| 3 |
NSAM
North Star Asset Management
Neenah,
Wisconsin
|
-$88.1K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$52.2K |
| 5 |
BA
Bard Associates
Chicago,
Illinois
|
-$39.6K |
HQL Hedge Fund Activity: Q3 2013 in Review
39 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q3 2013, worth a combined $46.1M — up 9% from $42.3M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new HQL positions and 1 closed out — a net gain of 7 holders — while 16 added to existing stakes and 9 trimmed.
The largest buyer was National Planning Corporation, opening a new position worth an estimated $580K. The largest seller was Advisors Asset Management, cutting an estimated $2.43M.
- 39 institutional investors held abrdn Life Sciences Investors (HQL) as of Q3 2013, up from 32 in Q2 2013.
- Funds reported $46.1M of abrdn Life Sciences Investors stock for Q3 2013, up 9% quarter-over-quarter.
- 8 funds opened new abrdn Life Sciences Investors positions in Q3 2013 and 1 closed out, a net change of +7 holders.
- The largest abrdn Life Sciences Investors buyer in Q3 2013 was National Planning Corporation, an estimated $580K added.
- The largest abrdn Life Sciences Investors seller in Q3 2013 was Advisors Asset Management, an estimated $2.43M sold.
Based on aggregated 13F filings for Q3 2013.